International Journal of Biochemistry, Biophysics & Molecular Biology

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

A Review on the Central Nervous System (CNS): Neurological Disorders and Plants with Therapeutic Effects on the CNS

The central nervous system (CNS) consists of the brain and the spinal cord. The central nervous system is a complex organ in the human being; it determines basic functions, such as consciousness, breathing, emotions and thoughts. Brain disorders can result directly from intrinsic dysfunction of the brain or complex interactions between the brain cells and the physical environment. A brain disorder associated with chronic break down and deterioration of neurons of the central nervous system is called a neurodegenerative disease. Statistics have shown that medicinal plants are being widely used in the treatment and management of diseases, such as malaria, diabetes, sickle-cell anemia and microbial infections. Some of these medicinal plants are also being used in the management of disorders of the CNS. These plants include Ginkgo biloba used in the management of symptoms associated with short term memory in Alzheimer’s disease and also in anxiety. Centella asiatica is also used as an anxiolytic agent in the management of epileptic symptoms. Piper methysticum is used to manage hallucination and also as a sedative. Compared to synthetic drug use, medicinal plant treatment is almost free from side effects, when compared to synthetic drug treatment; therefore, it is preferred over synthetic drugs. In conclusion, it can be inferred that the CNS play a vital part in the human body by transmitting impulses via the nerve cells. But unlike other cells of the body which have regenerative properties, the nerve cells lack the ability to regenerate itself this makes a single damage to one or more of the nerve cells a fatal blow to the entire behavioural functions of the body and also treatment of this cell next to impossible. Thus treatment and management of these disorders is a lifetime commitment which makes it necessary to introduce medicinal plants with therapeutic properties into the treatment strategy in other to minimize long-term side effects of synthetic drugs.

CNS, Medicinal Plant, Neurodegenerative Diseases, Ginkgo biloba, Alzheimers

APA Style

Bakare-Akpata Osarobo, Ighodaro Edwin Aigbogun, Ibukun Ereneh Azure. (2022). A Review on the Central Nervous System (CNS): Neurological Disorders and Plants with Therapeutic Effects on the CNS. International Journal of Biochemistry, Biophysics & Molecular Biology, 7(2), 55-61.

ACS Style

Bakare-Akpata Osarobo; Ighodaro Edwin Aigbogun; Ibukun Ereneh Azure. A Review on the Central Nervous System (CNS): Neurological Disorders and Plants with Therapeutic Effects on the CNS. Int. J. Biochem. Biophys. Mol. Biol. 2022, 7(2), 55-61. doi: 10.11648/j.ijbbmb.20220702.12

AMA Style

Bakare-Akpata Osarobo, Ighodaro Edwin Aigbogun, Ibukun Ereneh Azure. A Review on the Central Nervous System (CNS): Neurological Disorders and Plants with Therapeutic Effects on the CNS. Int J Biochem Biophys Mol Biol. 2022;7(2):55-61. doi: 10.11648/j.ijbbmb.20220702.12

Copyright © 2022 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License ( which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Wyburn, G. M. (1961). THE NERVOUS SYSTEM. The American Journal of the Medical Sciences, 242 (4, 521. doi: 10.1097/00000441-196110000-00022.
2. Bird, A. F. & Bird, J. (1991). The Nervous System. The Structure of Nematodes, 129-156. DOI:
3. Hall, R. (1998). Structure of the nervous system. International journal of neuroscience, 2 (8): 87-94.
4. Ganong, W. F. (1983). Excitable tissue: Nerve. Review of medical physiology, 31-44.
5. Baars, B. J. & Gage, N. M. (2010). Cognition, Brain and Consciousness. In Cognition, Brain and Consciousness. Elsevier Ltd.
6. Gautam, A. (2017). Nerve Cells. In: Vonk, J. & Shackelford, T. (eds) Encyclopedia of animal cognition and behavior. Springer International Publishing. pp: 1-4.
7. Webb, W. G. (2017). Neuronal Function in the Nervous System. Neurology for the Speech-Language Pathologist, 74-92.
8. Queensland Brain Institute (2018). Types of neurons. Retrieved February 20, 2022, from
9. Niyonambaza, S. D., Kumar, P., Xing, P., Mathault, J., De Koninck, P., Boisselier, E. & Boukadoum, M. et al. (2019). A review of neurotransmitters sensing methods for neuro-engineering research. Applied sciences, 9 (21), 4719.
10. Watson, D. & Dixon, E. (1998). Chemical Neurotransmitters in the Nervous System.
11. Cooper, J. R. (2001). Neurotransmitters. International Encyclopedia of the Social and Behavioral Sciences, 10612–10619. DOI:
12. Gopal, T., Divya, P., Hassamur, R., Harikesh, K., Srivastava, A. K. & Prakash, D. (2013). An Overview of Indian Traditional Medicinal Plants with Anti- Psychological Potentials. International Journal of Medicine and Pharmaceutical Research, 1 (4): 354-366.
13. Benedetti, F., Bernasconi, A. & Pontiggia, A. (2006) Depression and neurological disorders. Current Opinion in Psychiatry, 19: 14-18.
14. Martin, E. I., Ressler, K. J., Binder, E. & Nemeroff, C. B. (2009). The neurobiology of anxiety disorders: Brain imaging, genetics, and psych neuroendocrinology. Psychiatry Clinics of North America, 32: 549-575.
15. Malvi, R. K., Bigoniya, P., Sethi, S. & Jain, S. (2011). Medicinal plants used in the treatment of epilepsy. International Research Journal of Pharmacy, 2 (2): 32-39.
16. Brodtkorb, E., Torbergsen, T., Nakken, K. O, Andersen, K., Gimse, R. & Sjaastad, O. (1994). Epileptic seizures, arthrogryposis, and migrational brain disorders: a syndrome? Acta Neurologic Scandinavica, 90 (4): 232-240. 25.
17. DeLisi, L. E., Szulc, K. U., Bertisch, H. C., Majcher, M. & Brown, K. (2006). Understanding structural brain changes in schizophrenia. Dialogues in Clinical Neuroscience, 8: 71-78.
18. Adewusi, E. A., Moodley, N. & Steenkamp, V. (2010). Medicinal plants with cholinesterase inhibitory activity. African Journal of Biotechnology, 9 (49): 8257-8276.
19. Chiba, T., Nishimoto, I., Aiso, S. & Matsuoka, M. (2007). Neuroprotection against neurodegenerative diseases. Development of a novel hybrid neuroprotective peptide colivelin. Molecular Neurobiology, 35: 55-84.
20. Citron, M. (2004). Strategies for disease modification in Alzheimer’s disease. Nature Reviews Neuroscience, 5: 677-685.
21. Tedeschi, G., Cirillo, M., Tessitore, A. & Cirillo, S. (2008). Alzheimer's disease and other dementing conditions. Neurological. Sciences, 29 (1): 301-307.
22. Hassan, A. G., Balasubramanian, R., Masoud, A. D., Burkan, Z. E. & Sughir, A. (2014). Role of medicinal plants in neurodegenerative diseases with special emphasis to Alzheimers disease. International Journal of Phytopharmacology, 5: 454-462.
23. Perry, E. & Howes, J. R. (2010). Medicinal Plants and Dementia Therapy: Herbal Hopes for Brain Aging? CNS Neuroscience & Therapeutics, 17 (6): 683-698.
24. Balkrishna, A. & Misra, L. N. (2017). Ayurvedic Plants in Brain Disorders: The Herbal Hope. Journal of Traditional Medicine and Clinical Naturopathy, 6 (2): 1-9. DOI: 10.4172/2573-4555.100022.
25. Ríos, J. L., Onteniente, M., Picazo, D. & Montesinos, M. C. (2016). Medicinal Plants and Natural Products as Potential Sources for Antiparkinson Drugs. Planta Medica, 82 (11/12): 942-951.
26. Dar, R. A., Shahnawaz, M. & Qazi, P. H. (2017). General overview of medicinal plants: A review. The Journal of Phytopharmacology, 6 (6), 349-351.
27. Rasool Hassan, B. A. (2012). Medicinal Plants (Importance and Uses). Pharmaceutica Analytica Acta, 3 (10): 4172.
28. Sahoo, S. (2018). A review of some medicinal plants used for nervous disorders. Journal of Medicinal Plants Studies, 6 (1): 220-224.
29. Palhares, R. M., Gonçalves Drummond, M., dos Santos Alves Figueiredo Brasil, B., Pereira Cosenza, G. & das Graças Lins Brandão, M. et al. (2015). Medicinal Plants Recommended by the World Health Organization: DNA Barcode Identification Associated with Chemical Analyses Guarantees Their Quality. PLOS ONE, 10 (5): 1-29.
30. Kladar, N., Mrđanović, J., Anačkov, G., Šolajić, S., Gavarić, N., Srđenović, B. & Božin, B. (2017). Hypericum perforatum: Synthesis of Active Principles during Flowering and Fruitification—Novel Aspects of Biological Potential. Evidence-Based Complementary and Alternative Medicine, 2017, 1–11.
31. Budantsev, A. L., Prikhodko, V. A., Varganova, I. V., & Okovityi, S. V. (2021). Biological activity of Hypericum perforatum L. (Hypericaceae): A review. Pharmacy & Pharmacology, 9 (1), 17-31.
32. Jobst, K. A., McIntyre, M., St. George, D. & Whitelegg, M. J. (2000). Safety of St John's wort. Lancet, 355: 575-576.
33. Gulick, R., Lui, H., Anderson, R., Kollias, N., Hussey, S. & Crumpacker, C. (1992). Human hypericism: a photosensitivity reaction to hypericin (St. John's Wort). International AIDS conference, 8 (2): B90.
34. Erdelmeier, C. A. (1998). Hyperforin possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L. Pharmacopsychistry, 31: 2-6.
35. Mishra, L. C. (2004). Scientific basis for Ayurvedic therapies. In Alzheimer’s diseases, CRC Press., pp: 411 –426. ISNB: 9780203498583.
36. Almedia, J. C. & Grimsley, E. W. (1996). Coma from the health food store: interaction between kava and alprazolam. Annals of International Medicine, 25: 940-941.
37. Hammond, T. G. & Whitworth, J. A. (1981). Adverse reactions to ginseng. The Medical Journal of Australia, 1 (9): 492.
38. Baker, J. T., Borris, R. P., Carte, B., Cordell, G. A., Soejarto, D. D. & Cragg, G. M. et al. (1995). Natural product drug discovery and development: new perspectives on international collaboration. Journal of Natural Products, 58: 1325-1357.
39. Hu, S., Han, R., Mak, S. and Han, Y. (2011). Protection against 1-methyl- 4-phenylpyridinium ion (MPP+)-induced apoptosis by water extract of ginseng (Panax ginseng C. A. Meyer) in SH-SY5Y cells. Journal of Ethnopharmacology, 35: 34-42.